Quick Takeaways
- Nine Ten Capital Management LLC filed SCHEDULE 13G/A for iRadimed Corp Common (IRMD).
- Disclosed ownership: 3.4%.
- Date of event: 31 Dec 2025.
Nine Ten Capital Management LLC - 31 Dec 2025 SCHEDULE 13G/A Report for iRadimed Corp Common (IRMD)
- Filing Manager
- Nine Ten Capital Management LLC
- Reporting Manager
- Nine Ten Capital Management
- Security
- iRadimed Corp Common
- Symbol
- IRMD
- Shares outstanding
- 12,602,265 shares
- Disclosed Ownership
- 428,477 shares
- Ownership
- 3.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 10 Feb 2026, 13:20:14 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 13 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Nine Ten Capital Management LLC disclosed 3.4% ownership in iRadimed Corp Common (IRMD) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 13 Feb 2025.
- Current filing was accepted on 10 Feb 2026, 13:20.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Nine Ten Capital Management | 3.4% | 428,477 | 428,477 | Michelle Katauskas | CCO | ||
| Nine Ten Partners LP | 3.4% | 428,477 | 428,477 | Michelle Katauskas | CCO | ||
| Russell Mollen | 3.4% | 428,477 | 428,477 | Russell Mollen | President |